Loading...
Novel Peptide Vaccine GV1001 Rescues Hearing in Kanamycin/Furosemide-Treated Mice
The cell-penetrating peptide GV1001 has been investigated as an anticancer agent and recently demonstrated anti-oxidant and anti-inflammatory effects. It has shown a protective effect on a kanamycin (KM)-induced ototoxicity mouse model. In the present study, we administered GV1001 at different time...
Na minha lista:
| Udgivet i: | Front Cell Neurosci |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Frontiers Media S.A.
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5780435/ https://ncbi.nlm.nih.gov/pubmed/29403358 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fncel.2018.00003 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|